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Objective. The pulmonary artery catheter (PAC) remains topic of debate. Despite abundant data, it is of note that many trials
did not incorporate a treatment protocol. Methods. We retrospectively evaluated ﬂuid balances and catecholamine doses in septic
patients after the introduction of a PAC-based treatment protocol in comparison to historic controls. Results.2× 70 patients
were included. The ﬁrst day the PAC group had a signiﬁcantly higher positive ﬂuid balance in comparison to controls (6.1 ± 2.6
versus 3.8±2.4 litre, P<0.001). After 7 days the cumulative ﬂuid balance in the PAC group was signiﬁcantly lower than in controls
(9.4±7.4 versus 13±7.6 litre, P = 0.001). Maximum dose of norepinephrine was signiﬁcantly higher in the PAC group. Compared
to controls this was associated with a signiﬁcant reduction in ventilator and ICU days. Conclusions. Introduction of a PAC-based
treatment protocol in sepsis changed the administration of ﬂuid and vasopressors signiﬁcantly.
1.Introduction
The pulmonary artery catheter (PAC) by Swan and Ganz, in
the setting of critically ill patients, was originally introduced
to “apply physiologic principles to the understanding of
the circulatory abnormalities characterizing an illness in
an individual patient, and to provide a rational basis for
selection of therapy with objective, quantitative assessment
of patient response” [1, 2]. In the following decades, this
mechanistic perspective on the clinical relevance of PAC
and other monitoring devices was gradually abandoned and
replaced by “evidence-based medicine,” with emphasis on its
potentialvaluetoreducemorbidityandmortality.Eversince,
multiple randomised controlled trials in diﬀerent subsets of
ICUpatientshavebeenperformed,toevaluatetheuseofP A C
to improve outcome [3–7]. Lack of consistency in the results
of these trials have led many to believe that the use of PAC
should be done with great restraint [8]. Others, however,
have stressed the potential methodological drawbacks of
these trials, that may obscure underlying beneﬁcial eﬀects of
the use of PAC; correct measurement, correct interpretation,
and correct application of PAC-derived data are all essential
to the ﬁnal result [9, 10]. Today, many aspects of such
methodological ﬂaws have been acknowledged. Errors in
measurements [11, 12], delay in insertion of PAC in acutely
ill patients [13], misinterpretation of static ﬁlling pressures
as a marker of preload [14], absence of therapeutic strategies
[6, 7], as well as faulty supranormal endpoints [15]h a v e
all been reported. Furthermore, over the years the use of
PAC has shifted from intermittently measuring static ﬁlling
pressures towards a continuous indicator of (dis)balance
between oxygen supply (cardiac output) and consumption2 Critical Care Research and Practice
(mixed venous oxygen saturation, SvO2). Furthermore it
has now become a tool for the assessment of functional
hemodynamic parameters, such as ﬂuid responsiveness. To
our knowledge, data on the eﬀect of a PAC-based protocol,
that integrates most of these aspects seem to be lacking.
In the present study we aimed to evaluate the inﬂuence
of a PAC-based protocol on ﬂuid administration and cat-
echolamine use of well-trained intensivists in the speciﬁc
setting of critically ill patients with early-phase severe sep-
sis/septic shock. We chose this particular group of patients,
under the assumption that (a change in) hemodynamic
management might have considerable potential impact on
patient morbidity. Primary endpoints were the ﬂuid balance
after 24 hours and 7 days and maximum dose of dopamine
and norepinephrine within the ﬁrst 24 hours. Secondary
outcome variables were days on the ventilator and length of
stay (LOS) ICU.
2.MaterialandMethods
2.1. Patients. The study was performed in a closed-format
22-bed mixed ICU in a tertiary teaching hospital. After the
introduction of a PAC-based protocol for hemodynamic
management as standard treatment for patients with sepsis
as primary reason for ICU admittance, all patients ≥18 years
with severe sepsis and septic shock, according to interna-
tional criteria [16], were included in the study during an
18-month period in 2007-2008. The historic control group
was recruited from our database in a 2-year period in 2005-
2006 and matched for sepsis criteria in a 1:1 ratio from a
consecutive period prior to implementation of the protocol.
The experiment was conducted with the understanding and
the consent of the human subject. According to applicable
laws the need for ethical approval or individual consent was
waived.
2.2. Protocol. During the study period hemodynamic assess-
ment in patients with severe sepsis or septic shock was
achieved through continuous invasive monitoring of arterial
blood pressure and right heart catheterisation with con-
tinuous cardiac output and SvO2 measurement (Vigilance,
Edwards Lifesciences, Saint-Prex, Switzerland) within 4
hours after ICU admittance. Until a PAC was in place, the
use of ﬂuids and vasoactive drugs was at the discretion of
the attending physician, aiming at a minimal mean arterial
pressure (MAP) of 60mmHg. After insertion and calibration
of the PAC, treatment of circulatory failure was aimed at a
MAP ≥60mmHg in combination with a cardiac index (CI)
≥2.5L/m2/min and an SVO2 ≥70%. Achievement of these
endpoints was performed in the following strict hierarchical
order. (1) Exclusion of ﬂuid responsiveness by repeated
infusions of at least 250mL crystalloids, colloids, or blood
products, until the increase in left ventricular stroke volume
was less than 10% or until the pulmonary artery wedge
pressure exceeded 18mmHg. Fluid administration was also
stopped in case hemodynamic endpoints were fulﬁlled. (2)
Treatment of inadequate systemic oxygen supply, deﬁned
as a cardiac index <2.5L/m2/min or central venous oxygen
saturation <70%, with dopamine administered at up to
10μg/kg/min and additional enoximone in the event of an
inadequate response to dopamine. (3) Reversal of hypoten-
sion with norepinephrine in case of MAP <60mmHg despite
the aforementioned steps (Figure 1). Feedback on adequacy
of PAC measurements and compliance with the protocol was
given to the attending intensivists on a daily basis by an
independent observer.
Inthecontrolgrouphemodynamicmonitoringconsisted
of an indwelling arterial catheter and central venous line.
Treatment was aimed at a MAP ≥60mmHg and central
venous pressure (CVP) between 8 and 12mmHg. A closed-
format setting, as well as protocols for the use of antibi-
otics (including selective decontamination of the digestive
tract), tight glucose regulation, low tidal volume ventilation,
weaning, (enteral) nutrition, activated protein C and steroid
administration, and a general red blood cell transfusion
trigger (hematocrit <25%) were unaltered during the study
and control period.
2.3. Data Collection. The following data were recorded
at baseline: demographic characteristics; severity of illness
and predicted mortality consistent with APACHE IV [17],
SOFA [18] (calculated over the ﬁrst 24 hours following
ICU admission), and RIFLE [19] scores; hemodynamic
data including ﬂuid balance and dose of vasoactive drugs;
results of standard laboratory tests, including blood gases,
arterial lactate concentrations, blood cultures, and cultures
of specimens sampled from each presumed site of infection.
Daily routine recordings consisted of hemodynamic data,
ﬂuid balance, dose of vasoactive drugs, arterial lactate con-
centrations, and blood gases; SOFA and RIFLE scores were
calculated daily during each patient’s ICU stay. The presence
of ARDS was retrospectively established by an independent
observer by chest X-ray assessment in combination with gas
exchangecriteria[20].Survivalstatuswasconﬁrmedforeach
subject at the end of their hospitalisation.
2.4. Statistical Analysis. For continuous variables, data are
presented as mean ± SD or as medians and interquartile
ranges (IQRs) in case of nonnormal distribution. Diﬀerences
in baseline values and outcome parameters between groups
were compared using an independent sample t-test, or
Mann-Whitney test in case of nonnormal distribution.
Comparison of mortality rates across diﬀerent treatment
strategies was performed using the χ2 test. A two-sided
P value of <0.05 was considered statistically signiﬁcant.
Confounding of the group eﬀect on the primary endpoint
was analysed using multiple regression analyses. Variables
with signiﬁcant group diﬀerences at baseline were entered
individually and in combination in the regression model to
detectsigniﬁcantconfoundingeﬀects.TheStatisticalPackage
for Social Sciences (SPSS 15.1 for Windows, Chicago, IL,
USA) was used for statistical analyses. Sample size was
based on the following assumptions. According to a random
sample of 20 protocol-treated patients we estimated the ﬂuid
balance after 24 hours 5.7 ± 2.5 litres. With an alpha of 0.05
and a power of 0.9, it would require a sample size of 2 × 66
patients to detect a diﬀerence of at least 1 litre.Critical Care Research and Practice 3
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Figure 1: Treatment algorithm.
3. Results
In 2007 and 2008 70 patients fulﬁlling the criteria for
severe sepsis or septic shock were included in the study; 70
matched control patients were recruited from 2004 to 2006.
Protocolized resuscitation and pulmonary artery catheteri-
sation was performed successfully in all patients within 4
hours of ICU admittance. No PAC-related complications,
including pneumothorax, line-related sepsis, or knotting
were reported; median duration of PA catheterisation was 4
days. Baseline characteristics were balanced between groups
with the exception of a signiﬁcantly higher age, lactate, and
RIFLE score in the control group and higher SOFA score in
the PAC group (Table 1).
Primary Outcome. During the ﬁrst 24 hours patients
in the PAC group had a signiﬁcantly higher positive ﬂuid
balance in comparison to controls (6.1 ±2.6v e r s u s3 .8 ±2.4
litre, P<0.001). However, after 7 days the cumulative ﬂuid
balance in the PAC group was signiﬁcantly lower than in
controls (9.4 ± 7.4v e r s u s1 3± 7.6l i t r e ,P = 0.001; Table 2,
Figure 2). Use of norepinephrine was signiﬁcantly higher
in the PAC group, both in dose and number of patients,
but no diﬀerence in the use of dopamine between groups
was observed (Table 2). Multiple linear regression analyses
showed that the statistically signiﬁcant diﬀerence in ﬂuid
balance after day 1 between the groups was not altered after
correction for age, RIFLE score, lactate an SOFA score (P<
0.001).
Secondary Outcome. Median number of days on the
ventilator was signiﬁcantly lower in the PAC group in
comparison to controls: 7 (5–11) versus 10 (6–18) days,
P = 0.01 (Table 3). This was accompanied by a signiﬁcantly4 Critical Care Research and Practice
Table 1: Baseline characteristics.
Variables PAC (n = 70) Control (n = 70) P value
Male, n (%) 42 (61) 39 (56) 0.49
Age 62 ± 16 67 ± 13 0.02
APACHE IV 90 ± 47 88 ± 29 0.73
Predicted mortality APACHE IV (%) 43 ± 21 39 ± 16 0.36
SOFA 10 ± 38 ± 30 . 0 3
Source of infection
Lung 19 16
Abdominal 34 37
Urinary tract 4 5
Other 13 12
ARDS (n)4 5 0 . 1 9
Mean arterial pressure, mmHg 71 ± 12 68 ± 15 0.18
Heart rate, beats/min 110 ± 17 109 ± 20 0.82
Central venous pressure, mmHg 13 ± 51 2 ± 50 . 8 4
Ventilator, use of, n (%) 69 (99) 69 (99) 1.00
PEEP, cm H2O1 3 ± 31 3 ± 30 . 8 8
Lactate, mmol/L 2.4 (1.4–4.3) 3.5 (2.7–5.4) 0.001
RIFLE score on admission 0 (0-1) 0 (0–2) 0.002
PAC: pulmonary artery catheter, APACHE: acute physiology and chronic health evaluation, SOFA: sequential organ failure assessment, PEEP: positivee n d
expiratory pressure, RIFLE: risk injury failure loss and endstage. Data are presented as mean ± SD, median (IQR) or as numbers (%).
Table 2: Primary outcome variables: ﬂuid balance and use of vasoactive drugs.
PAC (n = 70) Control (n = 70) P value
Fluid balance day 0–4 hours (L) 2.0 ±1.41 .9 ±1.40 . 7 9
Fluid balance day 1 6.1 ±2.63 .8 ±2.4 0.000
Fluid balance day 2 3.7 ±2.04 .8 ±2.3 0.002
Fluid balance day 3 1.6 ±1.93 .2 ±2.4 0.000
Fluid balance day 4 −0.1 ±2.11 .4 ±2.6 0.000
Fluid balance day 5 −0.3 ±1.70 .1 ±2.20 . 1 3
Fluid balance day 6 −0.7 ±1.4 −0.5 ±2.10 . 2 6
Fluid balance day 7 −0.7 ±1.60 .1 ±2.20 . 0 1
Fluid balance day 1–7 9.4 ±7.41 3 ± 7.6 0.002
Maximum dose norepinephrine (μg/kg/min, n) 0.12 (0.03–0.19), 59 0.02 (0–0.17), 39 0.000
Maximum dose dopamine (μg/kg/min, n) 7.02 (4.7–9.8), 65 7.7 (4.7–9.6), 66 0.79
PAC: pulmonary artery catheter. Data are presented as mean ± SD, median (IQR) or as numbers.
shorter LOS ICU for patients in the PAC group, as compared
to controls: 9 (6–13) versus 14 (7–28) days, P < 0.001.
Post hoc univariate analysis revealed a signiﬁcant correlation
between the cumulative ﬂuid balance after 7 days and both
number of days on the ventilator (rs = 0.47, P<0.001) as
wellasLOSICU(rs =0.43,P<0.001).However,therewasno
correlation between the ﬂuid balance on day 1 and number
of days on the ventilator or LOS ICU (rs = 0.17, P = 0.06,
and rs = 0.13, P = 0.12, resp.; Figure 3).
4. Discussion
InthepresentstudyimplementationofaPAC-basedprotocol
for the hemodynamic management of patients with severe
sepsis and septic shock was associated with a considerable
impact on the use of volume resuscitation and vasopressors,
both in timing and total volume. In comparison to historic
controls, the PAC group received signiﬁcantly more ﬂuids
during the ﬁrst 24 hours. Interestingly this was accompaniedCritical Care Research and Practice 5
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Figure 2: Fluid balances in the ﬁrst week.
Table 3: Secondary outcome variables: morbidity and mortality.
Variables PAC (n = 70) Control (n = 70) P value
Days on ventilator 7 (5–11) 10 (6–18) 0.01
PO2/FiO2 ratio, worst (mmHg) 196 ± 81 158 ± 64 0.003
CVVH, n 28 35 0.24
CVVH, days 0 (−5) 0 (0–8) 0.08
RIFLE score, highest 2 (0–3) 3 (1–3) 0.02
LOS ICU (days) 9 (6–13) 14 (7–28) 0.001
LOS hospital 24 (14–40) 30 (17–51) 0.16
Cumulative SOFA score day 1–5 39 ± 15 40 ± 16 0.67
Cumulative SOFA score day 1–5 survivors 39 ± 12 38 ± 16 0.63
Mortality ICU (n, %) 15 (21) 21 (30) 0.33
Mortality hospital (%) 17 (24) 27 (39) 0.10
PAC:pulmonaryarterycatheter,FiO2:inspiratoryoxygenfraction,CVVH:continousvenovenoushemoﬁltration,RIFLE:riskinjuryfailurelossandendstage,
LOS: length of stay, SOFA: sequential organ failure assessment. Data are presented as mean ± SD, median (IQR) or as numbers (%).
by a signiﬁcant reduction in total ﬂuid administration in
the ﬁrst 7 days. These diﬀerences were not only statistically
signiﬁcant, but also associated with clinically relevant end-
points: reduction of days on the ventilator and LOS ICU.
In this respect, the setting in which the PAC-based
protocol was tested seems to be of great importance.
We speciﬁcally selected patients with assumed perfusion
abnormalities. In this setting of patients with severe sepsis
or septic shock, we anticipated a high likelihood to detect
diﬀerences in the early management of ﬂuids and vasoactive
drugs between conventional and PAC-based hemodynamic
treatment. This is in contrast to other groups of patients,
in which hemodynamic management may not be of equal
importance,forexample,inroutinenoncardiacsurgery[21].
Despite an overwhelming number of trials, addressing
the use of PAC in diﬀerent clinical subsets, there are not
many data speciﬁcally focussed on (diﬀerences) in the
use of ﬂuids, inotropes, and vasopressors, as a result of
a PAC-based treatment algorithm. The vast majority of
studies did not incorporate hemodynamic endpoints and/or
treatment protocols and failed to report how the use of PAC
changed therapeutic behaviour [7, 22]. Other studies aimed
for supranormal endpoints (CI, SvO2) generally considered
faulty in hindsight; interestingly in these trials only a minor-
ity of patients fulﬁlled endpoints [3, 15]. Furthermore, many
protocols were based on the incorrect assumption that static
ﬁlling pressures could predict cardiac response to volume
infusion [14] or formation of pulmonary oedema [23].6 Critical Care Research and Practice
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Figure 3: Linear regression analysis on the relation between the total number of days on the ventilator and the ﬂuid balance after 24 hours
(a), as well as the ﬂuid balance after 7 days (b).
The presented dynamics in ﬂuid administration (more
ﬂuids in the early phase, less ﬂuids later) show similarities
with previous data from hemodynamic endpoint-driven
treatment protocols in sepsis. After a S(c)vO2 -based protocol
diﬀerences in the use of ﬂuids in comparison to conventional
treatment were observed after 6 hours, rather than after
3d a y s[ 24]. In a retrospective study in patients with
septic shock and ARDS, both initial ﬂuid frontloading and
subsequent ﬂuid restriction were identiﬁed as markers of
morbidity and mortality [25]. In accordance with our data,
this was associated with increased use of norepinephrine, but
not dopamine. The importance of timing was illustrated by
the fact that the use of PAC in ARDS, after a mean period
of admittance to the ICU of >40 hours and a ﬂuid intake
>4900mL, wasnot associated with improvement inoutcome
[13]. Interestingly, we observed an association between LOS
ICU/number of days on the ventilator and the cumulative
ﬂuid balance after 7 days, but not after 24 hours. This may
be explained by the fact that pulmonary oedema formation
in sepsis may not occur during (early) volume loading in the
steep part of the cardiac function curve, as opposed to (late)
volume loading in the horizontal part of the curve [26].
It seems unlikely that the observed changes in ﬂuid
dynamics and vasopressor administration are restricted to
the use of the PAC itself. Guidance by other physiologic
variables,derivedfrompulsecontouranalysisoroesophageal
Doppler monitoring, were also associated with a change in
therapeutic behaviour [27–29].
Several limitations of the study need to be addressed.
Comparison between an intervention group and historic
controls may be biased by unknown changes in patient
management over time. The imbalance in lactate at baseline
between groups might reﬂect signiﬁcant diﬀerences in level
of resuscitation or case mix and, therefore, create a bias in
interpretation of the ﬂuid balances. To “correct” this to some
extentweperformedamultiplelinearregressionanalysisthat
included the diﬀerence in baseline lactate between groups,
and its potential inﬂuence in ﬂuid balance after day 1. After
correction for age, RIFLE score, lactate, and SOFA score, the
impact of the protocol remained highly signiﬁcant for the
primary endpoints (P<0.001). Similar considerations need
to be taken into account with respect to the imbalance in
RIFLE score at baseline. The presence of acute renal failure
at baseline is likely to be associated with LOS ICU and
mortality. Alternatively, a positive ﬂuid balance itself has
also been identiﬁed as an independent risk factor for the
occurrence of acute renal failure [30].
A single centre setup determines both skills in insertion
of PAC and correct measurements, as well as the use of
ﬂuidsandvasoactivedrugs“accordingtothediscretionofthe
attending physician.” Extrapolation to other settings should
therefore be done with great restraint. Although the relation
between primary and secondary outcome variables appear
to be relevant, one should realize that the number of days
on the ventilator and LOS ICU is surrogate endpoint for
ICU treatment. However, the number of patients in this
study was not adequate to detect potential diﬀerences in
hospital mortality. At best, our results can be considered as
hypothesis generating, rather than conclusive. Nevertheless,
the data seem to indicate that a PAC-based treatment
protocol,appliedtoaveryearlyphaseofadiseasestatewitha
highapriorichanceonhemodynamic-relatedmorbidityand
mortality, has considerable impact on ﬂuid and vasopressor
management in comparison to nonprotocolized treatment,
both in absolute numbers and dynamics. Future studies with
adequate design are necessary to establish its potential for
mortality reduction.
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